Preparation process of human prothrombin compound

A human prothrombin and preparation technology, applied in the field of biopharmaceuticals, can solve problems such as coagulation disorders, achieve the effects of reducing pollution, improving safety, and simplifying production steps
CN101974070AActive Publication Date: 2011-02-16华润博雅生物制药集团股份有限公司

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
华润博雅生物制药集团股份有限公司
Publication Date
2011-02-16
Patent Text Reader

Abstract

The invention relates to a preparation process of a human prothrombin compound, belonging to the field of biological pharmacy. The preparation process comprises the following steps of: absorbing blood plasma, washing, eluting and clarifying by filtration; inactivating viruses by using the S / D (Solvent / Detergent) method; purifying by absorption; subpackaging; freeze-drying; and inactivating viruses by the dry heat method. The human prothrombin compound is directly absorbed from blood plasma by using gel, only the gel chromatography technology is used in the entire extraction process, so that the production steps are simplified, the pollution of various factors on the production process of the product is reduced, meanwhile, the yield of the product is increased by 25-30%. In addition, the S / D method is used for removing lipid-enveloped viruses and the dry heat method is used for removing non lipid-enveloped viruses in the production process, and the safety of clinic medication is obviously increased through the two virus inactivation steps.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a preparation process of a human prothrombin complex, which belongs to the field of biopharmaceuticals. Background technique

[0002] The human prothrombin complex contains four coagulation factors II, VII, IX, and X that vitamin K depends on for its synthesis in the liver. Both vitamin K deficiency and severe liver disease can cause deficiency of these four factors. The lack of any of the above factors can lead to coagulation disorders. Infusion of human prothrombin complex can increase blood coagulation factor II, VII, IX, and X concentrations. Therefore, it is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency. The standard preparation method is: take freshly separated liquid plasma and frozen plasma from healthy blood donors, use direct gel adsorption method or low-temperature ethanol and polyethylene glycol method to separate protein from plasma, and use nationally ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More